BIOMAT Database Logo BIOMAT Database Logo

Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. 1997

A E Schnieke, and A J Kind, and W A Ritchie, and K Mycock, and A R Scott, and M Ritchie, and I Wilmut, and A Colman, and K H Campbell
PPL Therapeutics, Roslin, Midlothian, EH25 9PP, Scotland, UK.

Ovine primary fetal fibroblasts were cotransfected with a neomycin resistance marker gene (neo) and a human coagulation factor IX genomic construct designed for expression of the encoded protein in sheep milk. Two cloned transfectants and a population of neomycin (G418)-resistant cells were used as donors for nuclear transfer to enucleated oocytes. Six transgenic lambs were liveborn: Three produced from cloned cells contained factor IX and neo transgenes, whereas three produced from the uncloned population contained the marker gene only. Somatic cells can therefore be subjected to genetic manipulation in vitro and produce viable animals by nuclear transfer. Production of transgenic sheep by nuclear transfer requires fewer than half the animals needed for pronuclear microinjection.

UI MeSH Term Description Entries
D008297 Male Males
D008892 Milk The off-white liquid secreted by the mammary glands of humans and other mammals. It contains proteins, sugar, lipids, vitamins, and minerals. Cow Milk,Cow's Milk,Milk, Cow,Milk, Cow's
D009355 Neomycin Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis. Fradiomycin Sulfate,Neomycin Palmitate,Neomycin Sulfate
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004624 Embryo Transfer The transfer of mammalian embryos from an in vivo or in vitro environment to a suitable host to improve pregnancy or gestational outcome in human or animal. In human fertility treatment programs, preimplantation embryos ranging from the 4-cell stage to the blastocyst stage are transferred to the uterine cavity between 3-5 days after FERTILIZATION IN VITRO. Blastocyst Transfer,Tubal Embryo Transfer,Tubal Embryo Stage Transfer,Embryo Transfers,Transfer, Embryo,Transfers, Embryo
D005164 Factor IX Storage-stable blood coagulation factor acting in the intrinsic pathway of blood coagulation. Its activated form, IXa, forms a complex with factor VIII and calcium on platelet factor 3 to activate factor X to Xa. Deficiency of factor IX results in HEMOPHILIA B (Christmas Disease). Autoprothrombin II,Christmas Factor,Coagulation Factor IX,Plasma Thromboplastin Component,Blood Coagulation Factor IX,Factor 9,Factor IX Complex,Factor IX Fraction,Factor Nine,Factor IX, Coagulation
D005260 Female Females
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal

Related Publications

A E Schnieke, and A J Kind, and W A Ritchie, and K Mycock, and A R Scott, and M Ritchie, and I Wilmut, and A Colman, and K H Campbell
Recombinant human factor IX produced from transgenic porcine milk.
January 2014, BioMed research international,
A E Schnieke, and A J Kind, and W A Ritchie, and K Mycock, and A R Scott, and M Ritchie, and I Wilmut, and A Colman, and K H Campbell
Nuclear transfer in cattle with non-transfected and transfected fetal or cloned transgenic fetal and postnatal fibroblasts.
November 2001, Molecular reproduction and development,
A E Schnieke, and A J Kind, and W A Ritchie, and K Mycock, and A R Scott, and M Ritchie, and I Wilmut, and A Colman, and K H Campbell
Production of transgenic goats expressing human coagulation factor IX in the mammary glands after nuclear transfer using transfected fetal fibroblast cells.
February 2013, Transgenic research,
A E Schnieke, and A J Kind, and W A Ritchie, and K Mycock, and A R Scott, and M Ritchie, and I Wilmut, and A Colman, and K H Campbell
Cloned transgenic calves produced from nonquiescent fetal fibroblasts.
May 1998, Science (New York, N.Y.),
A E Schnieke, and A J Kind, and W A Ritchie, and K Mycock, and A R Scott, and M Ritchie, and I Wilmut, and A Colman, and K H Campbell
Transgenic cattle produced by nuclear transfer of fetal fibroblasts carrying Ipr1 gene at a specific locus.
September 2015, Theriogenology,
A E Schnieke, and A J Kind, and W A Ritchie, and K Mycock, and A R Scott, and M Ritchie, and I Wilmut, and A Colman, and K H Campbell
Studies of human factor IX by a high-titred sheep antiserum against factor IX.
November 1977, Thrombosis research,
A E Schnieke, and A J Kind, and W A Ritchie, and K Mycock, and A R Scott, and M Ritchie, and I Wilmut, and A Colman, and K H Campbell
Expression of human factor IX by microencapsulated recombinant fibroblasts.
June 1993, Human gene therapy,
A E Schnieke, and A J Kind, and W A Ritchie, and K Mycock, and A R Scott, and M Ritchie, and I Wilmut, and A Colman, and K H Campbell
Production of transgenic recloned piglets harboring the human granulocyte-macrophage colony stimulating factor (hGM-CSF) gene from porcine fetal fibroblasts by nuclear transfer.
December 2008, Theriogenology,
A E Schnieke, and A J Kind, and W A Ritchie, and K Mycock, and A R Scott, and M Ritchie, and I Wilmut, and A Colman, and K H Campbell
Expression of active human factor IX in transfected cells.
January 1985, Nature,
A E Schnieke, and A J Kind, and W A Ritchie, and K Mycock, and A R Scott, and M Ritchie, and I Wilmut, and A Colman, and K H Campbell
Biodistribution and pharmacokinetics of transgenic pig-produced recombinant human factor IX (rhFIX) in rats.
January 2008, In vivo (Athens, Greece),
Copied contents to your clipboard!